Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Identifying and targeting hypoxia in head and neck cancer: a brief overview of current approaches.

× No keyword cloud information.

17 in total

1. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer.

Authors: Johannes H A M Kaanders; Karien I E M Wijffels; Henri A M Marres; Anna S E Ljungkvist; Lucas A M Pop; Franciscus J A van den Hoogen; Peter C M de Wilde; Johan Bussink; James A Raleigh; Albert J van der Kogel
Journal: Cancer Res Date: 2002-12-01 Impact factor: 12.701

2. Serum levels of vascular endothelial growth factor in patients with head and neck cancer.

Authors: F Riedel; K Götte; J Schwalb; H Wirtz; W Bergler; K Hörmann
Journal: Eur Arch Otorhinolaryngol Date: 2000 Impact factor: 2.503

3. ARCON: experience in 215 patients with advanced head-and-neck cancer.

Authors: Johannes H A M Kaanders; Lucas A M Pop; Henri A M Marres; Ingolv Bruaset; Franciscus J A van den Hoogen; Matthijs A W Merkx; Albert J van der Kogel
Journal: Int J Radiat Oncol Biol Phys Date: 2002-03-01 Impact factor: 7.038

4. Do erythropoietin receptors on cancer cells explain unexpected clinical findings?

Authors: Michael Henke; Dominik Mattern; Margaret Pepe; Christina Bézay; Christian Weissenberger; Martin Werner; Frank Pajonk
Journal: J Clin Oncol Date: 2006-10-10 Impact factor: 44.544

5. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.

Authors: Matthias Bache; Rolf Reddemann; Harun M Said; Hans-Jürgen Holzhausen; Helge Taubert; Axel Becker; Thomas Kuhnt; Gabriele Hänsgen; Jürgen Dunst; Dirk Vordermark
Journal: Int J Radiat Oncol Biol Phys Date: 2006-10-23 Impact factor: 7.038

6. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study.

Authors: Marianne Nordsmark; Søren M Bentzen; Volker Rudat; David Brizel; Eric Lartigau; Peter Stadler; Axel Becker; Markus Adam; Michael Molls; Juergen Dunst; David J Terris; Jens Overgaard
Journal: Radiother Oncol Date: 2005-08-10 Impact factor: 6.280

7. Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial.

Authors: Jens Overgaard; Jesper Grau Eriksen; Marianne Nordsmark; Jan Alsner; Michael R Horsman
Journal: Lancet Oncol Date: 2005-08-27 Impact factor: 41.316

8. Detection of hypoxia in human squamous cell carcinoma by EF5 binding.

Authors: S M Evans; S Hahn; D R Pook; W T Jenkins; A A Chalian; P Zhang; C Stevens; R Weber; G Weinstein; I Benjamin; N Mirza; M Morgan; S Rubin; W G McKenna; E M Lord; C J Koch
Journal: Cancer Res Date: 2000-04-01 Impact factor: 12.701

9. Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas.

Authors: Quynh-Thu Le; Patrick D Sutphin; Soumya Raychaudhuri; Sheue Ching T Yu; David J Terris; Ho Sheng Lin; Bert Lum; Harlan A Pinto; Albert C Koong; Amato J Giaccia
Journal: Clin Cancer Res Date: 2003-01 Impact factor: 12.531

10. Mature results from a randomized Phase II trial of cisplatin plus 5-fluorouracil and radiotherapy with or without tirapazamine in patients with resectable Stage IV head and neck squamous cell carcinomas.

Authors: Quynh-Thu Le; Al Taira; Sherie Budenz; Mary Jo Dorie; Don R Goffinet; Willard E Fee; Richard Goode; Daniel Bloch; Albert Koong; J Martin Brown; Harlan A Pinto
Journal: Cancer Date: 2006-05-01 Impact factor: 6.860

8 in total

1. Hypoxia-induced autophagic response is associated with aggressive phenotype and elevated incidence of metastasis in orthotopic immunocompetent murine models of head and neck squamous cell carcinomas (HNSCC).

Authors: Nadarajah Vigneswaran; Jean Wu; Anren Song; Ananth Annapragada; Wolfgang Zacharias
Journal: Exp Mol Pathol Date: 2011-01-12 Impact factor: 3.362

Review 2. Osteopontin: an effector and an effect of tumor metastasis.

Authors: L A Shevde; S Das; D W Clark; R S Samant
Journal: Curr Mol Med Date: 2010-02 Impact factor: 2.222

3. The relationship between tumor volume changes and serial plasma osteopontin detection during radical radiotherapy of non-small-cell lung cancer.

Authors: Christian Ostheimer; Franziska Schweyer; Thomas Reese; Matthias Bache; Dirk Vordermark
Journal: Oncol Lett Date: 2016-09-08 Impact factor: 2.967

4. A pilot study on potential plasma hypoxia markers in the radiotherapy of non-small cell lung cancer. Osteopontin, carbonic anhydrase IX and vascular endothelial growth factor.

Authors: C Ostheimer; M Bache; A Güttler; M Kotzsch; D Vordermark
Journal: Strahlenther Onkol Date: 2013-12-11 Impact factor: 3.621

Review 5. Radioprotection.

Authors: Joel S Greenberger
Journal: In Vivo Date: 2009 Mar-Apr Impact factor: 2.155

6. Prognostic information of serial plasma osteopontin measurement in radiotherapy of non-small-cell lung cancer.

Authors: Christian Ostheimer; Matthias Bache; Antje Güttler; Thomas Reese; Dirk Vordermark
Journal: BMC Cancer Date: 2014-11-21 Impact factor: 4.430

7. Impact of tumoral carbonic anhydrase IX and Ki-67 expression on survival in oral squamous cell carcinoma patients.

Authors: Nigel T Brockton; Pawadee Lohavanichbutr; Emeka K Enwere; Melissa P Upton; Elizabeth N Kornaga; Steven C Nakoneshny; Pinaki Bose; Chu Chen; Joseph C Dort
Journal: Oncol Lett Date: 2017-08-25 Impact factor: 2.967

8. Remodelling of microRNAs in colorectal cancer by hypoxia alters metabolism profiles and 5-fluorouracil resistance.

Authors: Anke Nijhuis; Hannah Thompson; Julie Adam; Alexandra Parker; Luke Gammon; Amy Lewis; Jacob G Bundy; Tomoyoshi Soga; Aisha Jalaly; David Propper; Rosemary Jeffery; Nirosha Suraweera; Sarah McDonald; Mohamed A Thaha; Roger Feakins; Robert Lowe; Cleo L Bishop; Andrew Silver
Journal: Hum Mol Genet Date: 2017-04-15 Impact factor: 6.150

8 in total